Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Burning Rock Biotech Ltd. (BNR)

NASDAQ:BNR

BNR

Burning Rock Biotech

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding BNR?

Track your performance easily

Link Broker

Burning Rock Biotech (BNR) Stock Price & Analysis

82 Followers

BNR Stock Chart & Stats

Advanced Chart >

Day’s Range$0 - $0

52-Week Range$2.62 - $10.20

Previous Close$3.44

Volume19.86K

Average Volume (3M)31.01K

Market Cap

$36.88M

Enterprise ValueN/A

Total Cash (Recent Filing)$615.10M

Total Debt (Recent Filing)$12.32M

Price to Earnings (P/E)―

Beta1.33

Next Earnings

Nov 12, 2024

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-7.65

Shares Outstanding10,258,726

10 Day Avg. Volume20,312

30 Day Avg. Volume31,014

Standard Deviation0.20

R-Squared0.00124

Alpha-0.06

Financial Highlights & Ratios

Price to Book (P/B)0.05

Price to Sales (P/S)0.48

Price to Cash Flow (P/CF)-4.10

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/Revenue0.00

Enterprise Value/Gross Profit0.00

Enterprise Value/Ebitda0.00

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Burning Rock Biotech News

PremiumThe Fly

Burning Rock Biotech, Dizal announce NMPA approval for sunvozertinib CDx

30d ago

BNR

PremiumCompany Announcements

Burning Rock Biotech Announces Executive Changes

1M ago

BNR

PremiumThe Fly

Burning Rock Biotech CFO Leo Li resigns

1M ago

BNR

PremiumCompany Announcements

Burning Rock Biotech Strengthens Audit Committee

2M ago

BNR

PremiumCompany Announcements

Burning Rock Biotech Announces Board Resignation

2M ago

BNR

PremiumCompany Announcements

Burning Rock Biotech Q2 Earnings and Strategic Shift

3M ago

BNR

PremiumCompany Announcements

Burning Rock Biotech to Delist from LSE

3M ago

BNR

PremiumCompany Announcements

Burning Rock Biotech Regains NASDAQ Compliance

5M ago

BNR

See More BNR News >

Financials

Annual

Income Statement >

Ownership Overview

―

Insiders

4.33% Mutual Funds

1.32% Other Institutional Investors

94.34% Public Companies and

Individual Investors

Detailed Ownership Overview >

Risk Analysis

Main Risk Category

Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Detailed Risk Analysis >

BNR FAQ

What was Burning Rock Biotech Ltd.’s price range in the past 12 months?

Burning Rock Biotech Ltd. lowest stock price was $2.62 and its highest was $10.20 in the past 12 months.

What is Burning Rock Biotech Ltd.’s market cap?

Currently, no data Available

When is Burning Rock Biotech Ltd.’s upcoming earnings report date?

Burning Rock Biotech Ltd.’s upcoming earnings report date is Nov 12, 2024 which is in 2 days.

How were Burning Rock Biotech Ltd.’s earnings last quarter?

Burning Rock Biotech Ltd. released its earnings results on Aug 23, 2024. The company reported -$0.148 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.148.

Is Burning Rock Biotech Ltd. overvalued?

According to Wall Street analysts Burning Rock Biotech Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Burning Rock Biotech Ltd. pay dividends?

Burning Rock Biotech Ltd. does not currently pay dividends.

What is Burning Rock Biotech Ltd.’s EPS estimate?

Burning Rock Biotech Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Burning Rock Biotech Ltd. have?

Burning Rock Biotech Ltd. has 8,232,740 shares outstanding.

What happened to Burning Rock Biotech Ltd.’s price movement after its last earnings report?

Burning Rock Biotech Ltd. reported an EPS of -$0.148 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.832%.

Which hedge fund is a major shareholder of Burning Rock Biotech Ltd.?

Among the largest hedge funds holding Burning Rock Biotech Ltd.’s share is Bridgewater Associates, LP. It holds Burning Rock Biotech Ltd.’s shares valued at N/A.

---

Burning Rock Biotech Stock Smart Score

Unlock Smart Score

Hedge Fund Trend

Decreased

By 1.7K Shares
Last Quarter.

Technicals

Fundamentals

Return on Equity

-69.24%

Trailing 12-Months

Asset Growth

-23.12%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Burning Rock Biotech Ltd.

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and LungPlasma. The company has developed various cancer detection products , involving tumor targeting, oncomitant diagnosis of immune drugs, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress and detection of tumor sensitivity.

---

BNR Company Deck

---

BNR Earnings Call

Q1 2024

0:00 / 0:00

---

BNR Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","15":"$15","23":"$23","31":"$31","-1":"-$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">―</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,7,15,23,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2023","6":"Jun<br/>2023","9":"Sep<br/>2023","12":"Nov<br/>2023","25":"Nov<br/>2024"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.8,9.046153846153846,8.292307692307693,7.538461538461538,6.784615384615385,6.030769230769231,5.276923076923077,4.523076923076923,3.769230769230769,3.0153846153846153,2.2615384615384615,1.5076923076923077,0.7538461538461529,{"y":null,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.8,9.046153846153846,8.292307692307693,7.538461538461538,6.784615384615385,6.030769230769231,5.276923076923077,4.523076923076923,3.769230769230769,3.0153846153846153,2.2615384615384615,1.5076923076923077,0.7538461538461529,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.8,9.046153846153846,8.292307692307693,7.538461538461538,6.784615384615385,6.030769230769231,5.276923076923077,4.523076923076923,3.769230769230769,3.0153846153846153,2.2615384615384615,1.5076923076923077,0.7538461538461529,{"y":null,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.6,"date":1669852800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.5,"date":1672531200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.3,"date":1675209600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.1,"date":1677628800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.1,"date":1680307200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":30.9,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.8,"date":1685577600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.5,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.9,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.7,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":9.8,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":9.12,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":9.8,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >